What is the generic name?

SIROLIMUS

What is the Trade Name for SIROLIMUS?

FYARRO

What are the Indications for SIROLIMUS?

• 1 INDICATIONS AND USAGE FYARRO ‚Ñ¢ is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). FYARRO is an mTOR inhibitor indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). ( 1 )

References: https://open.fda.gov/